Clc1ccc(/C=C\c2nc(Cl)c(-c3ccc(Cl)cc3)c(Cl)n2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?